Last updated 2026-07-20
- Raised $50M Series A led by Accel, Apr 2025
- Raised $15M Seed round led by Exor, Dec 2022
Total raised
$65.0M
Last: Undisclosed Round 2025-05
Stage
Series A
Founded
2023
Headcount
45
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
PhaseV is an Israeli startup that develops an AI- and machine learning-enabled platform for clinical development solutions in the life sciences industry. The company's platform helps biopharma sponsors and clinical research organizations (CROs) with advanced insights across various domains, including clinical operations, causal disease modeling, treatment response pattern identification in complex heterogeneous data, and patient subgroup identification for precision medicine approaches. PhaseV aims to revolutionize drug development by integrating cutting-edge AI to enhance clinical trial processes, identify planning flaws, and better interpret trial results, ultimately increasing trial success rates, reducing costs, and accelerating time to market. PhaseV's platform has demonstrated a reduction in trial costs by 50%, a decrease in enrollment size and trial duration by 40%, and a more than 30% increase in the likelihood of trial success.
Funding history · 2 rounds · $65.0M total
2025-04
A Round
$50.0M
★ Accel★ Insight PartnersExorLionBirdViola Ventures
2022-12
Seed
$15.0M
★ Exor★ Viola VenturesGETTYLionBird
Headcount over time
From 15 (2023-06) to 53 (2026-03) · +38 (+253%) · 15 points · source: Finder history + radar grounding
Q&A
- What is PhaseV's primary focus?
- PhaseV develops a platform for adaptive clinical trial design and closed-loop execution, utilizing machine learning algorithms like reinforcement learning and causal ML to support clinical decisions.
- When was PhaseV founded?
- PhaseV was founded in January 2023.
- Where is PhaseV headquartered?
- PhaseV is headquartered in Tel Aviv-Yafo, Israel.
- What is PhaseV's total funding to date?
- PhaseV has raised a total of $65,000,000.
- When was PhaseV's last funding round and who were the lead investors?
- PhaseV's last funding round was in May 2025, with Insight Partners and Accel as lead investors.
- Which investors participated in PhaseV's January 2023 funding round?
- In January 2023, Viola Ventures and Exor were lead investors in PhaseV's funding round.
- What is PhaseV's current funding stage?
- PhaseV is currently in its Series A funding stage.
Team · 3
Raviv Pryluk
Founder · CEO & Co-founder
Elad Berkman
Founder · CTO & Co-founder
Dan Goldstaub
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical Workflow
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business model
B2B
Highlights
Verified
Tags
data-science-platformclinical-trialslife-sciencesmachine-learning
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | phasevtrials.com |
|---|---|
| linkedin.com/company/92848461 |
Identifiers & details
| Founded | 2023 |
|---|---|
| Employees (exact) | 45 |
Radar intelligence
Open jobs — greenhouse
| Total open | 12 |
|---|---|
| Remote | 0 |
| By department | Engineering (4), Business Development (3), Strategy and Transformation (1), Medical (1), Data Science (2), Marketing (1) |
| By location | One Broadway, 11th floor, Cambridge, MA 02142, USA (9), Dereck Ha'SHalom St 4 (3) |
| Title | Location | Department |
|---|---|---|
| Senior Backend Developer | One Broadway, 11th floor, Cambridge, MA 02142, USA | Engineering |
| Senior Director of Business Development | One Broadway, 11th floor, Cambridge, MA 02142, USA | Business Development |
| Strategy and Market Intelligence Intern | One Broadway, 11th floor, Cambridge, MA 02142, USA | Strategy and Transformation |
| Business Development Representative | One Broadway, 11th floor, Cambridge, MA 02142, USA | Business Development |
| Medical Director | One Broadway, 11th floor, Cambridge, MA 02142, USA | Medical |
| Associate Director / Director of Business Development | One Broadway, 11th floor, Cambridge, MA 02142, USA | Business Development |
| Biostatistics Researcher | One Broadway, 11th floor, Cambridge, MA 02142, USA | Data Science |
| Marketing Director | One Broadway, 11th floor, Cambridge, MA 02142, USA | Marketing |
| QA Engineer | Dereck Ha'SHalom St 4 | Engineering |
| Senior Backend Developer | Dereck Ha'SHalom St 4 | Engineering |
| Senior Data Scientist | One Broadway, 11th floor, Cambridge, MA 02142, USA | Data Science |
| Senior Product Manager | Dereck Ha'SHalom St 4 | Engineering |
Patents
| EPO | 2 |
|---|
Publications (Crossref)
| Works | 5 |
|---|
Web history (Wayback)
| Domain | phasevtrials.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516735404 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-01-04 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 1 |
| Registry events | 2 — other (1), charge (1) |
| Registered address | דרך השלום 4 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-26 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-02-08 | רישום שעבוד |